InfinityQS Demonstrates Quality’s Impact on the Vaccine Manufacturing Chain in New eBook

News   Oct 08, 2014

 
InfinityQS Demonstrates Quality’s Impact on the Vaccine Manufacturing Chain in New eBook
 
 
 

RELATED ARTICLES

Cobra Biologics Awarded £2.6m ($3.4m USD) from Innovate UK

News

Capital infrastructure investment to embed and secure clinical and commercial viral vector manufacturing capability within the UK. Award made as part of UK’s Innovation Agency’s Industrial Strategy boost for UK medicines with £70m of funding to help develop new treatments.

READ MORE

Eppendorf Hosts Second Stem Cell Community Day in Duesseldorf

News

The event brings together experts from industry and academia to discuss recent trends, achievements, and challenges in bioprocessing technologies for stem cell research. The conference is organized by leading life science company Eppendorf AG.

READ MORE

Boyds Acquires New Cambridge Office to Support Rapid Growth

News

Boyds, the drug development consultancy which helps pharmaceutical companies translate great science into marketable medicines for patient benefit, has relocated into new premises in Cambridge.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE